Residual Inflammation and Ulcerative Colitis in Remission

nork Moss, Alan C.
Argitaratua 2014

Optimizing the use of biological therapy in patients with inflammatory bowel disease

nork Moss, Alan C.
Argitaratua izan da Gastroenterol Rep (Oxf) (2015)

Putting TDM knowledge into practice

nork Moss, Alan C
Argitaratua izan da Frontline Gastroenterol (2019)

Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update

nork Lawlor, Garrett, Moss, Alan C
Argitaratua 2009

Mesalamine in the treatment and maintenance of remission of ulcerative colitis

nork Ham, Maggie, Moss, Alan C
Argitaratua 2012

Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX(®) mesalamine

nork Nanda, Kavinderjit, Moss, Alan C
Argitaratua 2012

Iron Replacement in Patients with Inflammatory Bowel Disease – A Systematic Review and Meta-Analysis

nork Abhyankar, Anita, Moss, Alan C
Argitaratua izan da Inflamm Bowel Dis (2015)

Novel treatment options for ulcerative colitis

nork Vaughn, Byron P, Moss, Alan C
Argitaratua 2013

Treatment of Crohn’s disease in pregnant women: Drug and multidisciplinary approaches

nork Cury, Didia Bismara, Moss, Alan C
Argitaratua 2014

Fecal Microbiota Transplantation: From Clostridium difficile to Inflammatory Bowel Disease

nork Gianotti, Robert J., Moss, Alan C.
Argitaratua izan da Gastroenterol Hepatol (N Y) (2017)

Exosomes in Intestinal Inflammation

nork Ayyar, Kanchana K., Moss, Alan C.
Argitaratua izan da Front Pharmacol (2021)

Implications of recurrent SARS-CoV-2 outbreaks for IBD management

nork Segal, Jonathan P, Moss, Alan C
Argitaratua izan da Frontline Gastroenterol (2020)

Impact of Antibodies to Infliximab on Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis

nork Nanda, Kavinderjit S., Cheifetz, Adam S., Moss, Alan C.
Argitaratua 2012

Systematic Review and Meta-Analysis: Serum Infliximab Levels During Maintenance Therapy and Outcomes in Inflammatory Bowel Disease

nork Moore, Clare, Corbett, Gillian, Moss, Alan C.
Argitaratua izan da J Crohns Colitis (2016)

Nephrolithiasis in patients with inflammatory bowel disease in the community

nork Cury, Dídia Bismara, Moss, Alan C, Schor, Nestor
Argitaratua 2013

Impact of inflammatory bowel disease activity and thiopurine therapy on birth weight: A meta-analysis

nork Gonzalez-Suarez, Begoña, Sengupta, Shreyashee, Moss, Alan C
Argitaratua izan da World J Gastroenterol (2017)

Palliative biliary stents for obstructing pancreatic carcinoma

nork Moss, Alan C, Morris, Eva, MacMathuna, Padraic
Argitaratua izan da Cochrane Database Syst Rev (2006)

Impact of Clinical Pharmacists in Inflammatory Bowel Disease Centers During the COVID-19 Pandemic

nork Bhat, Shubha, Farraye, Francis A., Moss, Alan C.
Argitaratua izan da Am J Gastroenterol (2020)

Outcomes after Infliximab Therapy Escalation in Ambulatory Patients with Moderately Active Ulcerative Colitis: Infliximab in Ulcerative Colitis

nork Rostholder, Emily, Ahmed, Awais, Cheifetz, Adam S, Moss, Alan C
Argitaratua 2012

In Silico Promoter Analysis can Predict Genes of Functional Relevance in Cell Proliferation: Validation in a Colon Cancer Model

nork Moss, Alan C., Doran, Peter P., MacMathuna, Padraic
Argitaratua 2007